Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic

被引:3
作者
Meredith, Luke W. [1 ]
Aboualy, Mustafa [1 ]
Ochola, Rachel [1 ]
Ozel, Mehmet [1 ]
Abubakar, Abdinasir [1 ]
Barakat, Amal [1 ]
机构
[1] WHO, Eastern Mediterranean Reg Off, Dept Hlth Emergency, Infect Hazard Management, Cairo, Egypt
关键词
COVID-19; EMRO; laboratory; quality; SARS-CoV-2; surveillance;
D O I
10.1111/irv.13217
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The COVID-19 pandemic placed unprecedented stress on laboratories in the Eastern Mediterranean Region. Building on existing capacity for influenza diagnostics, countries introduced COVID-19 diagnostic support to similar to 100% regional coverage. A key challenge during the expansion was maintaining quality testing in laboratories, ensuring that correct results were shared with medical facilities. Methods: WHO organized two rounds of independently monitored severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) external quality assurance programs (EQAP). The Public Health Laboratory (PHL) division of WHO supplied external quality assurance (EQA) panels, from the Royal College of Pathologists of Australasia Quality Assurance Programme (RCPAQAP) Australia to laboratories not enrolled in recurring Global Influenza Surveillance and Response System (GISRS) quality assurance programs, in which national influenza centers routinely participate. Results: Fifteen and 14 countries participated in PHL/EQAP for SARS-CoV-2 between 2020 and 2022. Concordance was consistent between rounds, reaching 96.4% and 89.9%. A separate assessment of GISRS/EQAP to national-level laboratories identified high levels of response and concordance for SARS-CoV-2 (100% response, 93% concordance), which was reduced for influenza (50% response rate, 80% concordance), reflecting the challenge of prioritizing pathogens during outbreaks. Conclusion: The proliferation of laboratories in response to COVID-19 was a success story from the pandemic. However, monitoring the quality of laboratories was challenging via existing EQAP. The addition of PHL/EQAP provided a mechanism to monitor performance of laboratories that were not designated as national influenza centers. While a high proportion of laboratories attained good results, continual emphasis on quality and enrollment in EQAP is key to ensuring sustainability of laboratory testing in future.
引用
收藏
页数:8
相关论文
共 24 条
  • [1] Genomic sequencing for epidemic and pandemic preparedness and response: EMRO?s vision and strategic interventions
    Al-Mandhari, Ahmed
    Barakat, Amal
    Abubakar, Abdinasir
    Brennan, Richard
    [J]. EASTERN MEDITERRANEAN HEALTH JOURNAL, 2022, 28 (12) : 851 - 852
  • [2] [Anonymous], United Kingdom Medicines and Healthcare Regulatory Agency, National Institute for Biological Standards and Control
  • [3] [Anonymous], European Virus Archive
  • [4] CDC, CDC Biorepository Program
  • [5] Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Publication with Expression of Concern)
    Corman, Victor M.
    Landt, Olfert
    Kaiser, Marco
    Molenkamp, Richard
    Meijer, Adam
    Chu, Daniel K. W.
    Bleicker, Tobias
    Bruenink, Sebastian
    Schneider, Julia
    Schmidt, Marie Luisa
    Mulders, Daphne G. J. C.
    Haagmans, Bart L.
    van der Veer, Bas
    van den Brink, Sharon
    Wijsman, Lisa
    Goderski, Gabriel
    Romette, Jean-Louis
    Ellis, Joanna
    Zambon, Maria
    Peiris, Malik
    Goossens, Herman
    Reusken, Chantal
    Koopmans, Marion P. G.
    Drosten, Christian
    [J]. EUROSURVEILLANCE, 2020, 25 (03) : 23 - 30
  • [6] One Health and planetary health research: leveraging differences to grow together
    de Castaneda, Rafael Ruiz
    Villers, Jennifer
    Guzman, Carlos A. Faerron
    Eslanloo, Turan
    de Paula, Nicole
    Machalaba, Catherine
    Zinsstag, Jakob
    Utzinger, Jurg
    Flahault, Antoine
    Bolon, Isabelle
    [J]. LANCET PLANETARY HEALTH, 2023, 7 (02) : E109 - E111
  • [7] The return of the seasonal flu and cold Other diseases are set to rebound as Covid-19 restrictions ease
    Hunter, Philip
    [J]. EMBO REPORTS, 2022, 23 (04)
  • [8] Impact of COVID-19 on laboratory professionals-A descriptive cross sectional survey at a clinical chemistry laboratory in a developing country
    Jafri, Lena
    Ahmed, Sibtain
    Siddiqui, Imran
    [J]. ANNALS OF MEDICINE AND SURGERY, 2020, 57 : 70 - 75
  • [9] COVID-19-another influential event impacts on laboratory medicine management
    Luo, YunTao
    Wang, JingHua
    Zhang, MinMin
    Wang, QingZhong
    Chen, Rong
    Wang, XueLiang
    Wang, HuaLiang
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (06)
  • [10] Applying a One Health Approach in Global Health and Medicine: Enhancing Involvement of Medical Schools and Global Health Centers
    Machalaba, Catherine
    Raufman, Jill
    Anyamba, Assaf
    Berrian, Amanda M.
    Berthe, Franck C. J.
    Gray, Gregory C.
    Jonas, Olga
    Karesh, William B.
    Larsen, Michelle H.
    Laxminarayan, Ramanan
    Madoff, Lawrence C.
    Martin, Keith
    Mazet, Jonna A. K.
    Mumford, Elizabeth
    Parker, Tina
    Pintea, Lilian
    Rostal, Melinda K.
    de Castaneda, Rafael Ruiz
    Vora, Neil M.
    Wannous, Chadia
    Weiss, Louis M.
    [J]. ANNALS OF GLOBAL HEALTH, 2021, 87 (01):